New Light-Based Technique Destroys 99% of Cancer Cells Without Chemotherapy

Scientists are advancing a promising cancer treatment that uses light to activate tiny molecules capable of destroying cancer cells without resorting directly to chemotherapy, surgery, or radiation therapy.

This method, called the "molecular hammer," involves medical molecules known as "aminosyanine," which are synthetic dyes currently utilized in medical imaging techniques. These molecules are activated by near-infrared light to produce mechanical motion inside cancer cells.

When exposed to the appropriate light, these molecules vibrate at an extremely high frequency—approximately 40 trillion oscillations per second—resulting in the rupture of the cancer cell membrane and eliminating the cells within minutes, even at low dosages.

Initial experimental results were published in the journal Nature Chemistry by a research team from Rice University, Texas A&M University, and the University of Texas. Laboratory tests demonstrated that the technique destroyed about 99% of cancer cells, and half of the mice with skin cancer were completely cured following the experimental treatment.

Following these findings, the researchers, led by chemist James Tour and colleagues, have continued refining the technique to enhance its precision in targeting various cancer types. Their latest study, published in Advanced Science, explores multiple forms of the molecular hammer, potentially broadening its future application against different tumor types.

Potential Approach for Pancreatic Cancer Treatment

The technique remains in its early stages, having been tested only in laboratory and animal models so far, without extensive human trials. Additional studies are required to confirm its safety and effectiveness in patients.

The researchers highlight that this method's distinctive feature is its reliance on direct mechanical effects, which may reduce the likelihood of cancer cells developing resistance, a common issue with some drug therapies.

The approach leverages a phenomenon called molecular plasmons, where electrons within the aminosyanine molecules move collectively when activated by light, causing the entire molecule to move and generate mechanical forces capable of damaging the cancer cell membrane.

These molecules include a component that enables them to adhere to cancer cells, and their rapid vibrations tear apart the surrounding membrane.

Using near-infrared light is a critical aspect of this technique because it can penetrate deeper into body tissues compared to visible light, potentially allowing future targeting of tumors located deep within bones or certain organs without surgical access.

The research team also investigated the toxicity risks associated with these molecules, finding that low doses of inactive molecular hammers are quickly absorbed and eliminated by healthy cells, suggesting preliminary indications of safe use in therapeutic applications.

While the researchers acknowledge that much work remains before the molecular hammer becomes an available treatment option, current results point to a promising direction in cancer research that employs mechanical motion at the molecular level to destroy diseased cells.